ArticleNature communications2026

Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.

Yabing Nan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.